Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bone, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bone, R. C.
(Chest. 1996;109:1056-1065.)
© 1996 American College of Chest Physicians

Goals of Asthma Management

A Step-Care Approach

Roger C. Bone MD, FCCP1

1 From the Medical College of Ohio, Toledo

The past 15 years have seen a rise in mortality and morbidity resulting from asthma, despite a concurrent rise in general knowledge about the disease. The step-care strategy recognized these changes in its approach to asthma management; however, this approach should be used only with attempts to control environmental allergens. Step-care therapy requires that patients be categorized by the severity of illness. Step-one therapy is used for mild, infrequent symptoms and involves treatment based primarily on inhaled bronchodilators. Step-two therapy is instituted in all asthmatics except the mildest cases; it involves treatment by inhaled corticosteroids, cromolyn, or nedocromil. Step-three treatment targets cases of severe asthma through the use of oral corticosteroids. In all phases of treatment, however, it should be remembered that patient education is of critical importance. Education improves patient compliance and is critical to the successful treatment of asthma.

Key Words: airway hyperresponsiveness • bronchodilator • circadian rhythm • cytokines • inflammatory response • mediators

Submitted on May 30, 1995
Accepted on November 7, 2007




This article has been cited by other articles:


Home page
 ThoraxHome page
B P A Thoonen, T R J Schermer, G van den Boom, J Molema, H Folgering, R P Akkermans, R Grol, C van Weel, and C P van Schayck
Self-management of asthma in general practice, asthma control and quality of life: a randomised controlled trial
Thorax, January 1, 2003; 58(1): 30 - 36.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
F. Gallefoss and P.S. Bakke
Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial
Eur. Respir. J., February 1, 2001; 17(2): 206 - 213.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
B. C. Carlstedt
Pharmacotherapy of Asthma
Journal of Pharmacy Practice, June 1, 1997; 10(3): 147 - 164.
[Abstract] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
K. A. Swanson
Meeting Patient Needs in Asthma Education
Journal of Pharmacy Practice, June 1, 1997; 10(3): 211 - 221.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American College of Chest Physicians.